Health Trials

Ischemic Cholangiopathy

2

Review clinical trials related to Ischemic Cholangiopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC).

A prospective, open-label, single-arm, investigator-initiated study (SELIC) to evaluate the efficacy and safety of seladelpar in adult liver transplant recipients with Ischemic cholangiopathy (IC).

Participants needed: 10
Trial details
Phase: Phase 2Age: 18-79Biological sex: AllType: InterventionalSponsor: University of California, San DiegoUpdated: Apr 9, 2026
Eligibility criteria

Adult, age ≥ 18 and < 80 years [+4]

Decompensated liver disease, including but not limited to ascites requiring para... [+8]

Read more
Status: Recruiting

Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.

The study will evaluate the results of endoscopic treatment of NON-anastomotic biliary strictures following liver transplantation

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSUpdated: Jan 29, 2026Locations: 1Duration: 2 Years
Eligibility criteria

Age > 18 [+4]

Previopus endoscopic or percutaneous treatments [+2]

Read more